Xbryk 120 mg/1.7 ml, Injektionslösung
7680698740018
CH-69874
Injektionslösung
Associated product:
XBRYK 120 mg/1.7 ml sol inj 120 mg 1 pce
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
denosumabum
|
120.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
polysorbatum 20
|
- | Substance | HNIDK |
|
sorbitolum
|
74.8 MG | Substance | HBESI |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 210.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/08/2026
Authorization holder
Samsung Bioepis CH GmbH
6005 Luzern
Authorization information
- Swissmedic authorization number
- 69874
- Drug name
- Xbryk, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- M05BX04
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 21/03/2025
- Authorization expiration date
- 20/03/2030
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- XBRYK 120 mg/1.7 ml sol inj 120 mg 1 pce
- Description (DE)
- XBRYK 120 mg/1.7 ml Inj Lös 120 mg 1 Stk
- Market launch
- 01/08/2026
- Narcotic (BTM)
- No